Answers are grounded in this paper and cite their sources.
The vaginal mucosa is a hormonally responsive barrier ecosystem in which epithelial integrity, immune tone and microbial composition are interconnected. In eubiotic states, estrogen-supported, Lactobacillus-dominated communities help maintain low pH, reinforce epithelial barrier function and modulate mucosal immunity through lactic acid and antimicrobial metabolites. Disruption of this equilibrium can lead to bacterial vaginosis (BV), a polymicrobial dysbiosis characterized by depletion of lactobacilli and formation of structured biofilms adherent to the vaginal epithelium. Genomic, transcriptomic and metabolomic studies increasingly support the view that BV reflects a spatially organized, metabolically integrated biofilm network rather than simple bacterial overgrowth. Gardnerella species are considered key early colonizers, forming an epithelial scaffold that recruits secondary anaerobes. Interspecies cross-feeding, glycan degradation, amine production and density-dependent regulation contribute to biofilm maturation, antimicrobial tolerance and persistence. These biofilms degrade mucus and weaken epithelial integrity through cytolytic and enzymatic activities, triggering low-grade mucosal inflammation with limited neutrophilic infiltration, favoring recurrence and increasing susceptibility to sexually transmitted infections and adverse reproductive outcomes. This review examines the establishment and organization of BV-associated polymicrobial biofilms in bacterial vaginosis, key interspecies interactions and virulence mechanisms, experimental approaches used to study these communities and implications of biofilm persistence for recurrence and emerging therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Bernard et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: